Loading...

ANIP ANI PHARMACEUTICALS INC Management Changes 8-K Filing

N PH

NP

ANI PHARMACEUTICALS INC

(ANIP)

2025 8-K

Board Transition Update

Investor Presentation Update

Financial Results

Preferred Shares Conversion

Investor Conference Update

Financial Statements

NEW DAY Study Results

Financial Statements

Investor Meetings

Investor Meetings

Financial Statements

Rights Offerings

Royalty Buy-Out

Investor Presentation

Financial Results

Investor Presentation

Financial Results

Investor Presentation

Financial Results

Earnings Report

Acquisition Completed

Private Offering

Financial Results Announcement

Merger Agreement

Results of Operations and F...

Departure of Directors or C...

Panel Discussion at Biotech...

Financial Results Announcement

Investor Meeting

Investor Presentation

Financial Results Announcement

Agreement for Sale of Manuf...

Presentation at Conference

Investor Presentation

Presentation at Conference

Financial Results Announcement

Presentation at Conference

Presentation to Investors

Presentation to Investors

Appointment of Director

Financial Results Announcement

Investor Presentation

Annual Meeting Approval

Sale of Common Stock

Public Offering

Underwritten Equity Offering

Policy Amendment and Direct...

Earnings Reports

FDIC Control of SVB

Earnings Reports

Bylaws Amendments

External Links:

On November 24, 2025, Patrick D. Walsh announced he will not seek re-election as a director at ANI Pharmaceuticals’ 2026 Annual Meeting but will remain until then; Thomas J. Haughey was elected as the new Chairman of the Board, with Jeanne A. Thoma taking over as Chair of the Audit and Finance Committee.

AI Assistant

ANI PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.